Caffeic acid phenethyl ester accumulates beta-catenin through GSK-3 beta and participates in proliferation through mTOR in C2C12 cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun Soo | - |
dc.contributor.author | Lee, Jung-Ok | - |
dc.contributor.author | Lee, Soo Kyung | - |
dc.contributor.author | Kim, Ji Hae | - |
dc.contributor.author | Jung, Jin Hee | - |
dc.contributor.author | Keum, Bora | - |
dc.contributor.author | Park, Sun-Hwa | - |
dc.contributor.author | Kim, Hyeon Soo | - |
dc.date.accessioned | 2021-09-08T16:58:18Z | - |
dc.date.available | 2021-09-08T16:58:18Z | - |
dc.date.issued | 2009-05-22 | - |
dc.identifier.issn | 0024-3205 | - |
dc.identifier.issn | 1879-0631 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/120031 | - |
dc.description.abstract | Aim: The aim of this study is to characterize the roles of caffeic acid phenethyl ester (CAPE) in the skeletal muscle cells. Main methods: We performed immunoblotting assay using various phosphorylation specific antibodies. Key findings: We found that CAPE induces rapid and transient phosphorylation of glycogen synthase kinase (GSK)-3 beta in a phosphoinositide 3-kinase (PI3K)-dependent manner. CAPE also decreases phosphorylation of beta-catenin, ultimately leading to beta-catenin accumulation. In addition, we demonstrated that CAPE activated the mammalian target of rapamycin (mTOR)-p70 S6 ribosomal kinase (S6K) and also stimulated extracellular signal-regulated kinase (ERK). The inhibition of mTOR blocked CAPE-induced ERK phosphorylation. Significance: Our results suggest that CAPE may act through beta-catenin accumulation via stimulation of GSK-3 beta and may also participate in cellular proliferation through the mTOR-ERK pathway. (C) 2009 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Caffeic acid phenethyl ester accumulates beta-catenin through GSK-3 beta and participates in proliferation through mTOR in C2C12 cells | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.lfs.2009.03.004 | - |
dc.identifier.scopusid | 2-s2.0-67349284717 | - |
dc.identifier.wosid | 000266281600008 | - |
dc.identifier.bibliographicCitation | LIFE SCIENCES, v.84, no.21-22, pp 755 - 759 | - |
dc.citation.title | LIFE SCIENCES | - |
dc.citation.volume | 84 | - |
dc.citation.number | 21-22 | - |
dc.citation.startPage | 755 | - |
dc.citation.endPage | 759 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | WNT SIGNALING PATHWAY | - |
dc.subject.keywordPlus | KAPPA-B | - |
dc.subject.keywordPlus | CAPE | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | RICTOR | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | ADHESION | - |
dc.subject.keywordAuthor | Akt | - |
dc.subject.keywordAuthor | beta-catenin | - |
dc.subject.keywordAuthor | CAPE | - |
dc.subject.keywordAuthor | GSK-3 beta | - |
dc.subject.keywordAuthor | mTOR | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.